EDWARDS LIFESCIENCES ENTERS INTO AGREEMENT TO ACQUIRE CARDIAQ IRVINE, CA, July 10, 2015 – Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has agreed to acquire CardiAQ Valve Technologies, Inc., a privately held company and developer of a transcatheter mitral valve replacement system.